Purolite announces two affinity chromatography resins

Sep 30, 2021 / Llantrisant, U.K.

Purolite, Cardiff, South Wales, 30th September 2021 - Purolite, a global manufacturer of resin-based chromatography separation, purification and extraction technologies, announced today the commercialization of two novel next- generation chromatography resins

Chris Major promoted to General Manager Agarose

Jun 21, 2021 / Llantrisant, Wales, U.K.

Purolite is happy to announce the promotion of Chris Major to General Manager Agarose

Virtual Groundbreaking - New Manufacturing Facility

May 11, 2021 /

We are excited to share that Purolite Corporation is expanding its manufacturing capabilities to the United States, addressing the global demand for its pharmaceutical and life science products.

Stephane Itart-Longueville joins Purolite

Feb 10, 2021 /

Stephane Itart-Longueville joins Purolite Healthcare & Life Sciences as Western Europe Sales Manager.

WuXi Biologics adopt Purolite Life Sciences Protein A resin for monoclonal antibody therapies

Nov 5, 2020 /

WuXi Biologics, a global company with leading open-access biologics technology, will utilize Praesto® Jetted A50 to provide their customers with additional choices for affinity chromatography resins for a range of downstream processes for monoclonal antibody purification.

Purolite secures funding to support essential industries during COVID-19

Apr 23, 2020 / Wales, UK

Purolite has secured funding from HSBC UK to support essential industries during the coronavirus outbreak.

Purolite donates PPE to local GP hub

Apr 23, 2020 / Wales, UK

Purolite has donated over 6000 pieces of PPE, including gloves and face masks to the Tonyrefail surgery to support the response to COVID-19.

Covid-19 Supply Statement

Apr 2, 2020 /

The latest supply statement from Purolite Life Sciences regarding Covid-19.

Protein A resin implemented into FDA-approved commercial manufacturing

Mar 6, 2020 / Wales, UK

Praesto Jetted A50 chromatography resin has been incorporated into the commercial manufacturing process of an FDA-approved monoclonal antibody treatment.

Purolite Life Sciences partner with Iosynth to offer increased support for biocatalysis process development

Dec 4, 2019 / Llantrisant, Wales

Purolite Life Sciences have joined forces with Iosynth, a biocatalysis service company offering specialist process development and optimization services to global pharma, agro chemical, cosmetics and fine chemical markets.

Praesto chromatography resins move into commercial manufacturing of FDA-approved biotherapeutics

Nov 21, 2019 / Llantrisant, South Wales

Purolite's Praesto range of agarose-based chromatography resins move into the commercial manufacturing of FDA-approved biotherapeutics.

Purolite announce partnership with PharmNXT Biotech in India

Apr 8, 2019 /

Purolite is pleased to announce our partnership with PharmNXT Biotech, for the supply and distribution of the Praesto® range of chromatography resins in India.

Purolite successfully secures funding to support a project exploiting Purolite ECR resins and immobilized enzymes.

Aug 1, 2018 /

We are pleased to announce that following a competitive bidding process run by Innovate UK, Purolite has successfully secured funding to support a project exploiting Purolite ECR resins and immobilised enzymes.

Purolite Life Sciences announces the launch of Praesto® Jetted A50

Jun 28, 2018 /

Purolite Life Sciences announces the launch of Praesto® Jetted A50 using proprietary Jetting technology | Leading the future of Protein A chromatography resins.

Purolite Selects Repligen’s Market-Leading Opus® Pre-Packed Columns

Nov 1, 2017 / Llantrisant, South Wales

Purolite Life Sciences today announced its collaboration with Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership and the maker of the market-leading OPUS® line of pre-packed chromatography columns.